Novo Biosciences achieves major milestones in moving trodusquemine into clinical trials
(Novo Biosciences ) Novo Biosciences Inc., has achieved several major milestones in its mission of bringing its breakthrough drug candidate, trodusquemine (aka MSI-1436), to market as a potential regenerative medicine treatment for heart disease and...